Elevance Health Inc. (ELV) Tops Q4 EPS by 3c; Offers 2023 Guidance

Elevance Health Inc. (NYSE: ELV) reported Q4 EPS of $5.23, $0.03 better than the analyst estimate of $5.20. Revenue for the quarter came in at $39.67 billion versus the consensus estimate of $39.72 billion.

GUIDANCE:

Elevance Health Inc. sees FY2023 EPS of $32.60, versus the consensus of $32.69. Elevance Health Inc. sees FY2023 revenue of $164 billion, versus the consensus of $163.9 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Goldman Sachs Assumes Klaviyo Inc (KVYO) at Buy
• Elevance Health Makes Clinical Review Faster, More Connected with Health OS